Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04145284 · ClinicalTrials.gov registry record
Quantitative Magnetic Resonance Imaging (MRI) Sub-Study of MS PATHS
A clinical trial of Multiple Sclerosis, sponsored by Biogen.
- Completed
- Registry status
- 6
- Enrollment target
- 2
- Study locations
NCT04145284: Completed study of Multiple Sclerosis, sponsored by Biogen.
NCT04145284 is a study of Multiple Sclerosis that has completed, run by Biogen. The registered enrollment target is 6 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04145284, a study of Multiple Sclerosis, has completed, sponsored by Biogen.
- COMPLETED
- Registry status
- 6 participants
- Enrollment target
- 2
- Study locations
Study Summary
The primary objective is to assess the performance of a new magnetic resonance imaging (MRI) metrics software prototype when used in radiological practice in multiple sclerosis (MS).
Primary Outcome
MRIs from participants will be analyzed by the prototype. The radiologist will view the brain segmentation results and the new or enlarging T2 lesion detection results. The radiologist will either "Approve" or "Reject" the results.
Conditions Studied
Study Locations (2)
Ohio
- Research Site - Cleveland
Saxony
- Research Site - Dresden
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2019-04-30 |
| Est. Completion | 2020-04-30 |
What the finished NCT04145284 record still lists
NCT04145284 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 0 interventions.
NCT04145284 reports a single indexed study location in Ohio, Saxony.
Frequently Asked Questions
What is clinical trial NCT04145284 about?
NCT04145284 is a clinical study titled "Quantitative Magnetic Resonance Imaging (MRI) Sub-Study of MS PATHS". The primary objective is to assess the performance of a new magnetic resonance imaging (MRI) metrics software prototype when used in radiological practice in multiple sclerosis (MS).
What is the current status of trial NCT04145284?
This trial is currently completed. The enrollment target is 6 participants. The study started on 2019-04-30. Estimated completion is 2020-04-30.
What conditions does trial NCT04145284 study?
This clinical trial studies the following conditions: Multiple Sclerosis.
Who is sponsoring clinical trial NCT04145284?
This trial is sponsored by Biogen, which has 334 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04145284 being conducted?
This trial has 2 study locations across Ohio, Saxony. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04145284's enrollment target sits among peer trials
6 312th of 315 higher than 3 of 315 other Multiple Sclerosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
RECRUITING · NA
-
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
RECRUITING · NA
-
Vancomycin Study in Multiple Sclerosis (MS)
RECRUITING · Phase 1
-
IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis
RECRUITING
-
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI